Diagnostic Quality Management Systems Information

NeoGenomics Laboratories, Inc. is fully licensed under the Clinical Laboratory Improvement Amendment of 1988 (“CLIA”) as well as accredited by the College of American Pathologists.


In addition, NeoGenomics maintains all necessary licenses required by all states in which it provides services, including but not limited to the States of New York and California.

NeoGenomics is committed to providing its services with the highest level quality and patient safety. This commitment is evident through our Quality Management System (“QMS”) which includes the following key elements:

  • Quality Expertise: We have dedicated department of quality professionals who manage and administer key elements of our QMS, such as licensure & credentialing, proficiency testing, document control and training & competency.
  • Test Performance: All tests are developed and validated in full compliance with all federal, state and local laws, rules and regulations, including CLIA, New York State and CAP standards. Test performance is routinely and closely monitored to ensure the timely delivery of accurate test results to our clients and their patients.
  • Staff Competency: All NeoGenomics' clinical laboratory personnel are required to have all appropriate credentials and experience to perform the tests provided by NeoGenomics. In addition, all NeoGenomics' personnel are required to participate in continual training and competency programs to ensure that each employee remains proficient and qualified to perform all testing with optimal expertise.
  • Process Improvement: NeoGenomics adheres to Lean and Six Sigma processes to ensure its continued excellence in services and reduce obstacles throughout in our process.

NeoGenomics' Regulatory and Licensing Information